{"name":"Jiangsu Healthy Life Innovation Medical Technology Co., Ltd","slug":"jiangsu-healthy-life-innovation-medical-technology-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwwJBVV95cUxQb2FqdjVZZUp3dGlZUnFkTmVoeTRQUlJTb1UwcTB2azlhUXFTRjNQRll0bWRzNTJoS0xybFlFZUx5ckJreE9oYXViNk80TlRVVDFyN3VUYXEyX2tVMFlwcV9kTlRsR29iam5idU15U2lHRDJYNm14MXdiXzRwVHNxa1FZN0hvS1l0cmZGYnNjZG90NnNwMVVKSkRkWmsyN2lzYWdFeVBLMmQ2by1GYmU5a3htUEs2MXd3T0pJOEtfLXpWVF9mTHI2ZHBRakpvMWNMT1NiOHFWOWJVWmlKblNsT0R1WE9wc0JJZWMxQko3ZHFIRVJPUUxjYUlET25OUVJXZWsxVm15MWNPMXlYWnNlYWZVSzBjaHhUcS1VeU5xbWtuMmNtX3J0NUkxZlBvaFhQQ2RTb1JpeGFza0NiX1R2VDJMSQ?oc=5","date":"2025-07-08","type":"regulatory","source":"Via Ritzau","summary":"Breakthrough in Ophthalmology! Hengrui’s Heng Qin® (Perfluorohexyloctane Eye Drops) Approved as First Treatment for Dry Eye Disease Associated with MGD - Via Ritzau","headline":"Breakthrough in Ophthalmology! Hengrui’s Heng Qin® (Perfluorohexyloctane Eye Drops) Approved as First Treatment for Dry ","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2025-07-01","type":"pipeline","source":"The Economic Times","summary":"Biological E to manufacture HPV9 vaccine for India, UNICEF and PAHO tender markets - The Economic Times","headline":"Biological E to manufacture HPV9 vaccine for India, UNICEF and PAHO tender markets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQX3Bnd0RBZDg1YmswRDdYMmktZ2pvbEk4V1lzRWNObTNPSkRDNW5kX0ZidU5kZEtMSG9RQVptNkhPRmpzUEpUdjdmdjJXdEJXWkFBQmU2QWd4bldvTnZ2WWdHSl80WVNmdmdTdWlKQjkzX2UwdFNuSUpIcDgxUXd0YXFHS2NYMzQzNm9QRHpYeEVTX3pESkVNN2Q0aURIcl9YTWJvQkdMOA?oc=5","date":"2025-05-16","type":"pipeline","source":"Grand View Research","summary":"China Food For Special Medical Purpose Market Report, 2030 - Grand View Research","headline":"China Food For Special Medical Purpose Market Report, 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgJBVV95cUxQeEhZSEZ1TFRjVWFST0xaVE5yeWRwTklDVXdCdmVjcVhPeFlQNkhJV0VMODNXN3gzZkhfMmxUT29qekpvZ3Ewcy1zTUYydG9YSk5HSHZzWHk1SGUtZFdYNDd4Q2tadlJDblNGOWgtZ1F5NTNOLVlJdDVlZjY5Y0RETk5sanFmSTBGOWFUR0tWOWVEWDhUeXFmNTNRTTlLRWtqT1UwenZJaFZqQW9EaXZza2N6TlFrc2NxY3dhYzRsNW4yMkZ1dHl0eEQ1aUNCMVVVaGxXMlB0bDZPT3lMOVZWM2tKMFg2Ylh4cndBa0JrRDNxUUhZTndVYzRXUVdXR0p2NnJXSnFJQ1VXTVdHRkNVLWVvZkhOS3B5WnRhRW5FamdlY1NOSjBOZi1xLV9obXQwTmRXck1R?oc=5","date":"2025-03-25","type":"deal","source":"BioSpace","summary":"Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein(a) Inhibitor, for Cardiovascular Disease from Jiangsu Hengrui Pharmaceuticals Co., Ltd. - BioSpace","headline":"Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein(a) Inhibitor, for Cardiovascu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE9HdVFJblRJZEFjQmJqakxTZDA5UkdhYTVHRUZCMTAtTGZlMzFRcVdORG1PbVRnQWZzN0RHNGlJaHRzZFlWUnVaX2toWVp6WWhVODRja0JjT3NFNVlVcVFUZUozRHlHVnpCSHZkOE12WFd3YkNqcFkw?oc=5","date":"2024-12-17","type":"pipeline","source":"Yicai Global","summary":"Guangshengtang's innovative drugs were included in the Breakthrough Therapy Variety List, and these companies also had drugs selected - Yicai Global","headline":"Guangshengtang's innovative drugs were included in the Breakthrough Therapy Variety List, and these companies also had d","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQZGpUbXVJS0lFdGVUQXZkemNmaV9WQ1pXVVczby1zU3dJV1FJc3ZzNUlBNjZMamE1czVxakZhbGt1VV9NWDY2OUFYc1FuTmhRMFg0NkwxQzlpQ21ldFJNVGEtU1VCeFMtV01QMXNQYW9TNmVhb3laZGlJb0NSdzBvLTdBT0QySU5kU0RuUmZCRXBDQThValFIUFU3VkpQeVdxaU9aNVNTb3IzRjc5YUo5N1ZrUVRwQUN3NHJ2Sk02b0hfdXVUUkYzZkc4bzhjaE1Oc1UycnZzaElGRnJieTdrXw?oc=5","date":"2024-07-30","type":"pipeline","source":"BioSpace","summary":"China Pharmaceutical Market Estimated to Reach a CAGR of 7.50% during 2024-2032, Impelled by the Rising Geriatric Population - BioSpace","headline":"China Pharmaceutical Market Estimated to Reach a CAGR of 7.50% during 2024-2032, Impelled by the Rising Geriatric Popula","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAJBVV95cUxPWTNpXzFFQXFPYWhIZExUZ3RsWDVKQlZCZThDUGtyUFNVOUdSZ09hNTJYc3F3TUZBbkdNRWFrcmM2Xy12THV2Uks0UjdvZlBVQWJTb2dFLTlCQkxjaXhMWUs2Q1M1OWVRaUhwRS1NT0hDeTRYQjRpRW5PRzNhUE9ST0NaWDhETXlyb0J6bkJtZmlKUkQ5OVR3M0dOeDhQS0g5ek9RcnVINDM2dlNLWU5BVlFienJVaWRTdUhMU2VEWVdBOGtRZTlpUllFMkNkX01lbDRBWWxZTnZNNHNhdmR6MXhweU9hZXNCSUpSZWlPV1ZxXzZwZXVGS3FTalRiclJiLXJ4alVtVU02bGJfVnE1RllHaHEyZDVqVGg1R3kxN0hmTVBPc0Job19QYkZ5cmFLY0EzU1BseklEYlh0WFhyaV9fdmFtaS1PeVE0Tg?oc=5","date":"2024-02-07","type":"deal","source":"BioSpace","summary":"Mycovia Pharmaceuticals, Inc. Announces Partner Jiangsu Hengrui Pharmaceuticals Co., Ltd's Commercial Launch of VIVJOA® (Oteseconazole) Capsules for the Treatment of Severe Vulvovaginal Candidiasis (V","headline":"Mycovia Pharmaceuticals, Inc. Announces Partner Jiangsu Hengrui Pharmaceuticals Co., Ltd's Commercial Launch of VIVJOA® ","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}